Literature DB >> 11127710

Immunohistochemical and molecular analysis in recurrent urethral stricture.

G Morgia1, A Saita, M Falsaperla, A Spampinato, M Motta, S Cordaro.   

Abstract

The authors have analyzed the most recent additions to the literature of immunohistochemical and molecular assessment of acquired urethral strictures and report on their data obtained in a selected clinical series. Innovative immunohistochemical studies in patients presenting with plurirecurrent symptoms suggest that urethral mesenchymal changes caused by tissue de-epithelialization may be the underlying cause of stricture. This condition may be congenital or acquired. It may determine aberrant connective tissue formation induced by abnormal fibroblastic activation with formation of over abundant hyperdense collagen scar tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127710     DOI: 10.1007/s002400000119

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  4 in total

1.  Preliminary experimental study of urethral reconstruction with tissue engineering and RNA interference techniques.

Authors:  Chao Li; Yue-Min Xu; Hong-Bin Li
Journal:  Asian J Androl       Date:  2013-04-01       Impact factor: 3.285

2.  Crosstalk between TGF-β1 and CXCR3 signaling during urethral fibrosis.

Authors:  Hong Xie; Chao Feng; Qiang Fu; Ying-Long Sa; Yue-Min Xu
Journal:  Mol Cell Biochem       Date:  2014-06-07       Impact factor: 3.396

3.  The dose-dependence biological effect of laser fluence on rabbit fibroblasts derived from urethral scar.

Authors:  Yong Yang; Bo Yu; Dongchong Sun; Yuanyi Wu; Yi Xiao
Journal:  Lasers Med Sci       Date:  2014-11-12       Impact factor: 3.161

4.  Application of Wnt Pathway Inhibitor Delivering Scaffold for Inhibiting Fibrosis in Urethra Strictures: In Vitro and in Vivo Study.

Authors:  Kaile Zhang; Xuran Guo; Weixin Zhao; Guoguang Niu; Xiumei Mo; Qiang Fu
Journal:  Int J Mol Sci       Date:  2015-11-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.